Back to Rankings

MOLN

Molecular PartnersD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
MOLN vs peer average
50/100
MOLN vs. peer average (D vs. D)
Grade spread
A 1 · C 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

SPRO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $163.86M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerSPROSpero Therapeutics
MOLN
Molecular Partners
SPRO
Spero Therapeutics
Grade
D
F
Momentum
38
5
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs SPRO

MOLN / SPRO
Grade Position
In line
MOLN vs. peer average (D vs. D)
50/100
Momentum
38
MOLN
Value
41
MOLN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MOLN
1
SPRO
Spero Therapeutics Inc Common
F
20/100
+1
2
QTRX
Quanterix Corp Common
F
20/100
+1
3
PLX
Protalix Biotherapeutics Inc Common
A
100/100
-3
4
ORMP
Oramed Pharmaceuticals Inc Common
F
20/100
+1
5
TLSA
Tiziana Life Sciences Ltd Common
F
20/100
+1
SPRO is the first peer returned for this comparison set.